Improved Seizure Control in Patients with Recurrent Glioblastoma Treated with Bevacizumab

Overview

Journal Neuro Oncol

Publisher Oxford University Press

Specialties Neurology
Oncology

Date 2022 Jul 30

PMID 35906902

Authors

Caroline Hertler

Katharina Seystahl

Emilie Le Rhun

Hans-Georg Wirsching

Patrick Roth

Michael Weller

Dorothee Gramatzki

Affiliations

Soon will be listed here.

Citing Articles

Patient-Centered Management of Brain Tumor-Related Epilepsy.

Dorotan M, Tobochnik S Curr Neurol Neurosci Rep. 2024; 24(9):413-422.

PMID: 39017829 DOI: 10.1007/s11910-024-01360-z.

Avila E, Tobochnik S, Inati S, Koekkoek J, McKhann G, Riviello J Neuro Oncol. 2023; 26(1):7-24.

PMID: 37699031 PMC: 10768995. DOI: 10.1093/neuonc/noad154.

Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial.

Ranjan T, Sengupta S, Glantz M, Green R, Yu A, Aregawi D Cell Rep Med. 2023; 4(5):101025.

PMID: 37137304 PMC: 10213810. DOI: 10.1016/j.xcrm.2023.101025.

Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management.

Filippone A, Mannino D, Casili G, Lanza M, Paterniti I, Cuzzocrea S Int J Mol Sci. 2022; 23(24).

PMID: 36555334 PMC: 9778944. DOI: 10.3390/ijms232415693.

Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours.

Horbinski C, Berger T, Packer R, Wen P Nat Rev Neurol. 2022; 18(9):515-529.

PMID: 35729337 DOI: 10.1038/s41582-022-00679-w.

References

Gramatzki D, Roth P, Rushing E, Weller J, Andratschke N, Hofer S . Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study. Ann Oncol. 2018; 29(6):1431-1436. DOI: 10.1093/annonc/mdy106. View

Wen P, Weller M, Quant Lee E, Alexander B, Barnholtz-Sloan J, Barthel F . Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol. 2020; 22(8):1073-1113. PMC: 7594557. DOI: 10.1093/neuonc/noaa106. View

Mastall M, Wolpert F, Gramatzki D, Imbach L, Becker D, Schmick A . Survival of brain tumour patients with epilepsy. Brain. 2021; 144(11):3322-3327. DOI: 10.1093/brain/awab188. View

Louis D, Perry A, Wesseling P, Brat D, Cree I, Figarella-Branger D . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021; 23(8):1231-1251. PMC: 8328013. DOI: 10.1093/neuonc/noab106. View

Climans S, Brandes A, Cairncross J, Ding K, Fay M, Laperriere N . Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients. J Neurooncol. 2020; 149(1):65-71. DOI: 10.1007/s11060-020-03573-x. View